Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
BioLargo, Inc. (OTCQX: BLGO) regularly issues news and updates about its cleantech, environmental, energy, and life sciences activities. As a developer of sustainable technologies and a full-service environmental engineering company, its announcements often focus on progress in PFAS water treatment, advanced wastewater solutions, odor and VOC control, air quality, energy storage, and medical infection control and wound care.
Recent news has highlighted BioLargo’s Aqueous Electrostatic Concentrator (AEC) platform, including reported breakthroughs that significantly reduced the system’s energy use in large-scale PFAS treatment and its deployment at a municipal drinking water facility in Lake Stockholm, New Jersey. Coverage also includes recognition of BioLargo Equipment Solutions & Technologies, Inc. in industry media for PFAS treatment advances and updates on commercial demonstration projects.
Investors and observers can also find announcements about BioLargo’s Cellinity battery technology for grid-scale energy storage, its role in broader infrastructure and clean energy discussions, and participation in conferences and investor events such as LD Micro and NobleCon. These items provide context on how the company positions its technologies within evolving infrastructure, data center, and energy investment cycles.
On the life sciences side, news items cover Clyra Medical Technologies’ progress in infection control and advanced wound care, including the ViaCLYR wound irrigation solution and its exclusive distribution alliance with Advanced Solution, LLC. Regulatory, legal, and corporate developments—such as SEC-reported events, financial updates, and intellectual property enforcement actions related to odor control technologies—are also common topics. This news page allows readers to follow BioLargo’s ongoing technical milestones, commercialization steps, and corporate disclosures in one place.
BioLargo, Inc. (OTCQB:BLGO) reported significant growth in its Q3 2022 results, achieving a 111% increase in revenue, totaling $1.5 million. For the nine months ending September 30, 2022, revenue reached $3.79 million, a 117% increase from 2021. The company highlighted successful partnerships, notably in pet odor control, and advancing its PFAS treatment technology. Noteworthy is ONM Environmental's growth, with revenues of $1.2 million this quarter. The company anticipates continued growth and expansion in the environmental engineering sector.
BioLargo, Inc. (OTCQB:BLGO) announced an investor webcast and conference call on November 16, 2022, at 2:00 PM Pacific/5:00 PM Eastern. The session will cover financial results for the three and nine months ending September 30, 2022, recent milestones, and a Q&A. Attendees can access the live broadcast via this link. BioLargo specializes in sustainable technologies and environmental engineering, holding numerous patents and partnerships aimed at addressing environmental challenges.
BioLargo, Inc. (OTCQB:BLGO) announced key results from its municipal wastewater treatment pilot at a conference in Halifax, Nova Scotia. The company showcased its patented Advanced Oxidation System (AOS), demonstrating a significant improvement in removing pharmaceutical micropollutants from wastewater. Over 18 months of testing at a facility near Montreal, the AOS increased removal efficiency to 84%-100%, compared to less effective current technologies. The company aims to position the AOS as a leader in the expanding market for micropollutant treatment as regulatory concerns grow worldwide.
BioLargo, Inc. (OTCQB: BLGO) announced the addition of two new board members, Linda Park and Christina Bray, enhancing its leadership team. Park, an executive with over 20 years of experience in corporate governance, previously worked with Edward Lifesciences and Western Digital. Bray, a finance specialist and CEO of Bluedot Energies, is recognized for her expertise in renewable energy technologies and capital projects. The company aims to leverage their experience to advance its cleantech vision. Retiring board members have transitioned to advisory positions.
BioLargo, Inc. (OTCQB:BLGO) reported a new quarterly revenue record of approximately $1.5 million for Q3 2022, up 13% from Q2 2022 and 111% year-over-year. The company’s growth was driven primarily by sales of its POOPH pet odor product. CEO Dennis P. Calvert emphasized ongoing expansion efforts and upcoming launches, including a PFAS removal project and consumer product rollouts. The full financial results are expected to be filed with the SEC by November 14, 2022, along with a planned investor webcast.
BioLargo, Inc. (OTCQB:BLGO) has entered a channel partnership agreement with Product Recovery Management (PRM), based in Butner, NC, to distribute BioLargo's water treatment systems and serve as a contract manufacturer. PRM will sell and distribute innovative technologies such as the Aqueous Electrostatic Concentrator (AEC) and Advanced Oxidation System (AOS), focusing on PFAS contamination solutions. This collaboration aims to leverage PRM's manufacturing capabilities and expertise in environmental remediation to meet growing demand for effective water treatment solutions.
BioLargo, Inc. (OTCQB:BLGO) reported strong growth in its quarterly report for Q2 2022, with consolidated revenue reaching $1.32 million, marking a 185% increase year-over-year. The company's subsidiaries, ONM Environmental and BioLargo Engineering, recorded significant revenue gains and returned to net operating income. BioLargo secured its first PFAS client, expanding its commercial reach, particularly with its white-label pet odor control product, POOPH. Upcoming projects with Garratt-Callahan and continuing engineering initiatives indicate a positive outlook.
BioLargo, Inc. (OTCQB:BLGO) will hold a public investor webcast and conference call on August 17, 2022, at 1:00 PM Pacific / 4:00 PM Eastern. The session aims to discuss the company's financial results for the six months ending June 30, 2022, review recent milestones, and engage in a Q&A. Interested participants can access the webcast via a provided link and join the teleconference using specified numbers. The event also serves to highlight BioLargo's innovative solutions in environmental technology.
BioLargo, Inc. (OTCQB:BLGO) has announced securing its first customer for a PFAS mitigation plan and establishing a partnership to market its PFAS treatment equipment. The customer contract marks the beginning of a multi-phase project aimed at addressing per- and polyfluoroalkyl substances (PFAS), which are harmful chemicals affecting health and the environment. The new channel partner will aid in distributing the company's engineering services and treatment technologies, including the proprietary Aqueous Electrostatic Concentrator (AEC).
BioLargo, Inc. (OTCQB:BLGO) reported approximately $1.3 million in revenue for Q2 2022, a 37% increase from Q1 and a 185% increase compared to Q2 2021. The company attributes this growth to expanding sales of the POOPH product, the anticipated launch of PFAS treatment technology, and larger engineering projects. The revenue figures are preliminary and may change pending accounting review. Full results will be available in the quarterly report due by August 15, 2022. An investor webcast will follow the report's release.